These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 3465751

  • 1. Effects of different transferrin forms on transferrin receptor expression, iron uptake, and cellular proliferation of human leukemic HL60 cells. Mechanisms responsible for the specific cytotoxicity of transferrin-gallium.
    Chitambar CR, Seligman PA.
    J Clin Invest; 1986 Dec; 78(6):1538-46. PubMed ID: 3465751
    [Abstract] [Full Text] [Related]

  • 2. Effects of transferrin-indium on cellular proliferation of a human leukemia cell line.
    Moran PL, Seligman PA.
    Cancer Res; 1989 Aug 01; 49(15):4237-41. PubMed ID: 2743310
    [Abstract] [Full Text] [Related]

  • 3. Uptake of gallium-67 by human leukemic cells: demonstration of transferrin receptor-dependent and transferrin-independent mechanisms.
    Chitambar CR, Zivkovic Z.
    Cancer Res; 1987 Aug 01; 47(15):3929-34. PubMed ID: 3475168
    [Abstract] [Full Text] [Related]

  • 4. Development of drug resistance to gallium nitrate through modulation of cellular iron uptake.
    Chitambar CR, Zivkovic-Gilgenbach Z, Narasimhan J, Antholine WE.
    Cancer Res; 1990 Aug 01; 50(15):4468-72. PubMed ID: 2164439
    [Abstract] [Full Text] [Related]

  • 5. Regulation of transferrin receptor expression on human leukemic cells during proliferation and induction of differentiation. Effects of gallium and dimethylsulfoxide.
    Chitambar CR, Massey EJ, Seligman PA.
    J Clin Invest; 1983 Oct 01; 72(4):1314-25. PubMed ID: 6313760
    [Abstract] [Full Text] [Related]

  • 6. Regulatory effects of gallium on transferrin-independent iron uptake by human leukemic HL60 cells.
    Chitambar CR, Sax D.
    Blood; 1992 Jul 15; 80(2):505-11. PubMed ID: 1627803
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Modulation of lymphocyte proliferation and immunoglobulin production by transferrin-gallium.
    Chitambar CR, Seigneuret MC, Matthaeus WG, Lum LG.
    Cancer Res; 1989 Mar 01; 49(5):1125-9. PubMed ID: 2537143
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Characterization of the transferrin receptor in UMR-106-01 osteoblast-like cells.
    Kasai K, Hori MT, Goodman WG.
    Endocrinology; 1990 Mar 01; 126(3):1742-9. PubMed ID: 2307125
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of transferrin and gallium-pyridoxal isonicotinoyl hydrazone as potential therapeutic agents to overcome lymphoid leukemic cell resistance to gallium nitrate.
    Chitambar CR, Boon P, Wereley JP.
    Clin Cancer Res; 1996 Jun 01; 2(6):1009-15. PubMed ID: 9816262
    [Abstract] [Full Text] [Related]

  • 19. Gallium-pyridoxal isonicotinoyl hydrazone (Ga-PIH), a novel cytotoxic gallium complex. A comparative study with gallium nitrate.
    Knorr GM, Chitambar CR.
    Anticancer Res; 1998 Jun 01; 18(3A):1733-7. PubMed ID: 9673397
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.